They started this research in 2012 based on “ostepontin” protein potential. That means they are building their portfolio on a decade old findings.
Also, have we ever heard “ostepontin” before? And how does it stand in the light of recent discoveries (Tregs, CxxxC5, Lactose)?
I expect nothing from them. In fact, in my opinion, at the moment 80% of all research in the pipeline will end up in the bin. Only 10 – 5% have a slight chance.
This is how bad it is at the moment.
I agree with you on that. I don’t think this is going anywhere.